Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Fosun International ( (HK:0656) ) just unveiled an update.
Fosun International Limited successfully passed an ordinary resolution at its extraordinary general meeting on October 23, 2025, approving the adoption of the 2025 H Share RSU Scheme for Fosun Pharma. This decision reflects the company’s strategic move to enhance its equity incentive plans, potentially strengthening its market position and aligning interests with stakeholders.
The most recent analyst rating on (HK:0656) stock is a Hold with a HK$5.50 price target. To see the full list of analyst forecasts on Fosun International stock, see the HK:0656 Stock Forecast page.
More about Fosun International
Fosun International Limited is a conglomerate with diverse business interests, including pharmaceuticals, real estate, and financial services, focusing on creating value through innovation and global operations.
Average Trading Volume: 15,302,783
Technical Sentiment Signal: Hold
Current Market Cap: HK$42.36B
For an in-depth examination of 0656 stock, go to TipRanks’ Overview page.